Skip to main content
Caplight Logo









FastBack Bio

FastBack Bio

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://fastback.bio

Company Overview

FastBack Bio is a biotechnology company with a novel CAR-T platform to develop T cell-based therapeutics and gene therapies to cure cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

CAR-T therapysolid tumor therapycell therapycell and gene therapyCGTco-stimulatory domainT-cell exhaustionM83 domainimmunotherapybiotech licensingoncologypreclinical biotechdrug developmentcell therapy manufacturingrenal cell carcinoma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FastBack Bio Comparables

Compare FastBack Bio with similar companies based on industry and business-model similarity.

FastBack Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inceptor Bio
86%
AffyImmune Therapeutics
77%
Roche Holding
70%

FastBack Bio Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

FastBack Bio Filings

Explore SEC and related filing metadata, where available.

FastBack Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about FastBack Bio's valuation, stock price, and market status.

Is FastBack Bio a public or private company?

FastBack Bio is a private company.

What is the current stock price of FastBack Bio?

FastBack Bio is a private company with no public stock price. No recent secondary market data is available.

How much is FastBack Bio worth (valuation)?

Valuation information for FastBack Bio is not publicly available.

Can I buy FastBack Bio stock?

FastBack Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was FastBack Bio's last funding round?

Funding round information for FastBack Bio is not publicly available.

Who are the main investors in FastBack Bio?

Investor information for FastBack Bio is not publicly disclosed.

Will FastBack Bio IPO soon?

No public IPO plans have been announced for FastBack Bio.

How can I track FastBack Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FastBack Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRaleigh, North Carolina
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?